Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J. Abraham Simón-Campos"'
Autor:
Timothy E. Albertson, Caitlin Hansen, Smiti Bihari, Juleen Gayed, Xia Xu, J. Abraham Simón-Campos, Michael E. Dever, Jose F. Cardona, Essack Mitha, Jeffrey B. Baker, Georgina Keep, Islamiat Oladipupo, Federico J. Mensa, Ye Feng, Hua Ma, Kenneth Koury, Susan Mather, Claudia Ana Ianos, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, William C. Gruber, Alejandra Gurtman, Charu Sabharwal, Nicholas Kitchin, the C4591031, C4591007 Clinical Trial Groups
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 4, Pp 699-714 (2024)
Abstract Introduction Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participant
Externí odkaz:
https://doaj.org/article/90c062f7697b4812bbed4dc9541f00d7
Autor:
Bonnie Vlahos, Gaston Solano, J Abraham Simón-Campos, Cecilia Borlenghi, Generoso Guerra Bautista, Ricardo Machado Xavier, Maria de la Vega, Ronald Pedersen
Publikováno v:
Open Access Rheumatology : Research and Reviews
Generoso Guerra Bautista,1 Ricardo Machado Xavier,2 Maria de la Vega,3 J Abraham Simón-Campos,4 Gastón Solano,5 Ronald D Pedersen,6 Bonnie Vlahos,6 Cecilia Borlenghi7 1Centro de Investigación Marbella, Paitilla Panamá, Panamá; 2Hospital de Clín
Autor:
Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, Aamer Ikram, Fernando Lanas, M Lourdes Guerrero, Sergio Raúl Muñoz Navarro, Omar Sued, Dmitry A Lioznov, Vitalina Dzutseva, Ghazala Parveen, Fengcai Zhu, Laura Leppan, Joanne M Langley, Luis Barreto, Jinbo Gou, Tao Zhu, Helen Mao, Luc Gagnon, Steven-Phay Tran, Sarwat Tahsin Khan, Amalia Guadalupe Becerra Aquino, Edgar Eduardo Saldaña Montemayor, Norma Eréndira Rivera Martínez, Víctor Casildo Bohórquez López, J. Abraham Simón Campos, Felipe de Jesús Pineda Cárdenas, Wei Chen, Lihua Hou, Zhe Zhang, Gonzalo Corral, Eduardo López, Ricardo Teijeiro, Maria F. Alzogaray, Cesar Zaidman, Gustavo Lopardo, Bernardo Goecke, Rosa María Feijooó Seoane, Sayed Faisal Mahmood, Ejaz Ahmed Khan, Jayed Akram, Salma Abbas, Naseem Salahuddin, Elena Rozhkova, Tatyana Zubkova
Publikováno v:
Lancet (London, England)
Background The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in phase 1 and 2 studies. In this study, we report results on the final efficacy
Autor:
David M, Weinreich, Sumathi, Sivapalasingam, Thomas, Norton, Shazia, Ali, Haitao, Gao, Rafia, Bhore, Jing, Xiao, Andrea T, Hooper, Jennifer D, Hamilton, Bret J, Musser, Diana, Rofail, Mohamed, Hussein, Joseph, Im, Dominique Y, Atmodjo, Christina, Perry, Cynthia, Pan, Adnan, Mahmood, Romana, Hosain, John D, Davis, Kenneth C, Turner, Alina, Baum, Christos A, Kyratsous, Yunji, Kim, Amanda, Cook, Wendy, Kampman, Lilia, Roque-Guerrero, Gerard, Acloque, Hessam, Aazami, Kevin, Cannon, J Abraham, Simón-Campos, Joseph A, Bocchini, Bari, Kowal, A Thomas, DiCioccio, Yuhwen, Soo, Gregory P, Geba, Neil, Stahl, Leah, Lipsich, Ned, Braunstein, Gary, Herman, George D, Yancopoulos, Raji, Ayinla
Publikováno v:
The New England Journal of Medicine
Background In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the monoclonal antibodies casirivimab and imdevimab, reduced the viral load and number of medical visits in patients with coronavirus disease 2019 (Covid-19). REG